J., Hoek, H
This precision approach moves beyond one-size-fits-all weight management, allowing your provider to make informed adjustments to your therapy at the starting dose or during titration
On the research side, Eli Lilly's orforglipron, an oral non-peptide small-molecule GLP-1 receptor agonist, has reported positive Phase 3 results but is not FDA-approved as of April 2026, so it is not yet a purchasable pill
Chen Q, Zhuang H, Liu Y (2012) The association between obesity factor and esophageal cancer
BBL Photofacial The BBL (BroadBand Light) Photofacial is a cutting-edge treatment that uses light energy to target and treat various skin imperfections such as sun damage, age spots, rosacea, and uneven skin tone
The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial